The Ecosystem of Patient Support Programs (PSPs) in India
Shubhra Seal1, Arun Kumar S2, Gramle Amol3, Nafisa Vaz4

1Shubhra Seal, Management Trainee, Healthcare and Life sciences, Hexaware Technologies, Pune, India.
2Arun Kumar S*, Intern, Consulting and Solutioning BioQuest Solutions Pvt. Ltd., Bengaluru, India.
3Dr Amol Gramle, Vice President, Consulting and Solutioning, BioQuest Solutions Pvt. Ltd., Bengaluru, India.
4Nafisa Vaz, Professor, Goa Institute of Management, Goa, India.
Manuscript received on June 08, 2021. | Revised Manuscript received on June 10, 2021. | Manuscript published on June 30, 2021. | PP: 32-36 | Volume-5 Issue-10, June 2021. | Retrieval Number: 100.1/ijmh.J13330651021 | DOI: 10.35940/ijmh.J1333.0651021
Open Access | Ethics and Policies | Cite
© The Authors. Published By: Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Abstract: The incidence and prevalence of non-communicable diseases are on the rise. Such diseases require prolonged treatment and it is of utmost importance to be compliant to treatment. Pharmaceutical companies are moving from traditional marketing to “beyond the pill” marketing to foster patient centricity. These companies also have a motive to conduct sustained sales of their products for the prolonged treatment tenures. For this reason, pharmaceutical companies have come up with support programs to promote treatment adherence. In India, support programs are also conducted by the Government, peer support groups, home healthcare and animal-assisted therapy. Detailed primary research and its analysis have been conducted to look at different parameters discussed in the study. A model for an ideal patient support program has been provided.
Keywords: Patient Support, Adherence, Diabetes, Cancer, Pharmaceutical Company, Patient Assistance.